| MedAvante is the world's leading provider of centralized assessments to enhance assay sensitivity in clinical drug trials of treatments for central nervous system (CNS) disorders. MedAvante clinicians directly interview trial subjects via live, remote telecommunications links or evaluate assessments from investigative sites using recordings and documents. Using MedAvante centralized assessment services will:
|  | Ensure blinding from any information that could prime or bias evaluations
| | Maximize standardization to decreases placebo response and improve signal detection | |